Brought to you by 
Amylin gets $18.5mm in private placement
02 Nov 1999
Executive Summary
In a private placement yielding $18.5mm, metabolic disorders specialist Amylin Pharmaceuticals sold to a group of institutional and private investors 3.7mm of its common shares at $5 each (a (pr)10% premium to its 10-day trailing average price).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Amylin gets $18.5mm in private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice